These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8621857)
1. The effects of prednisolone on the cutaneous tuberculin response in patients with corticosteroid-resistant bronchial asthma. Sousa AR; Lane SJ; Atkinson BA; Poston RN; Lee TH J Allergy Clin Immunol; 1996 Feb; 97(2):698-706. PubMed ID: 8621857 [TBL] [Abstract][Full Text] [Related]
2. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation. Sousa AR; Lane SJ; Soh C; Lee TH J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):565-74. PubMed ID: 10482829 [TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Lock SH; Kay AB; Barnes NC Am J Respir Crit Care Med; 1996 Feb; 153(2):509-14. PubMed ID: 8564089 [TBL] [Abstract][Full Text] [Related]
4. Eosinophil cationic protein in serum of corticosteroid-sensitive and resistant bronchial asthma. Patkowski J; Wytrychowski K; Medrala W Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):195-200. PubMed ID: 9597087 [TBL] [Abstract][Full Text] [Related]
5. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Bentley AM; Hamid Q; Robinson DS; Schotman E; Meng Q; Assoufi B; Kay AB; Durham SR Am J Respir Crit Care Med; 1996 Feb; 153(2):551-6. PubMed ID: 8564096 [TBL] [Abstract][Full Text] [Related]
6. Responsiveness to oral prednisolone in severe asthma is related to the degree of eosinophilic airway inflammation. Sousa AR; Marshall RP; Warnock LC; Bolton S; Hastie A; Symon F; Hargadon B; Marshall H; Richardson M; Brightling CE; Haldar P; Milone R; Chalk P; Williamson R; Panettieri R; Knowles R; Bleecker ER; Wardlaw AJ Clin Exp Allergy; 2017 Jul; 47(7):890-899. PubMed ID: 28493293 [TBL] [Abstract][Full Text] [Related]
7. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. Hanania NA; Sockrider M; Castro M; Holbrook JT; Tonascia J; Wise R; Atmar RL; J Allergy Clin Immunol; 2004 Apr; 113(4):717-24. PubMed ID: 15100679 [TBL] [Abstract][Full Text] [Related]
8. Reaction to intradermally applied phytohaemagglutinin in asthma patients in relation to corticosteroid therapy. Kruszewski J; Płusa T; Szczylik C; Wiktor-Jedrzejczak W Allergy; 1983 Apr; 38(3):201-5. PubMed ID: 6846748 [TBL] [Abstract][Full Text] [Related]
9. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Robinson D; Hamid Q; Ying S; Bentley A; Assoufi B; Durham S; Kay AB Am Rev Respir Dis; 1993 Aug; 148(2):401-6. PubMed ID: 8342904 [TBL] [Abstract][Full Text] [Related]
10. Corticosteroid-resistant chronic asthma and monocyte complement receptors. Kay AB; Diaz P; Carmicheal J; Grant IW Clin Exp Immunol; 1981 Jun; 44(3):576-80. PubMed ID: 7326867 [TBL] [Abstract][Full Text] [Related]
11. Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Meijer RJ; Kerstjens HA; Arends LR; Kauffman HF; Koëter GH; Postma DS Thorax; 1999 Oct; 54(10):894-9. PubMed ID: 10491451 [TBL] [Abstract][Full Text] [Related]
12. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Djukanović R; Homeyard S; Gratziou C; Madden J; Walls A; Montefort S; Peroni D; Polosa R; Holgate S; Howarth P Am J Respir Crit Care Med; 1997 Mar; 155(3):826-32. PubMed ID: 9117012 [TBL] [Abstract][Full Text] [Related]
13. Corticosteroid resistance in chronic asthma. Carmichael J; Paterson IC; Diaz P; Crompton GK; Kay AB; Grant IW Br Med J (Clin Res Ed); 1981 May; 282(6274):1419-22. PubMed ID: 6784848 [TBL] [Abstract][Full Text] [Related]
15. Effects of prednisolone on bone turnover in patients with corticosteroid resistant asthma. Lane SJ; Vaja S; Swaminathan R; Lee TH Clin Exp Allergy; 1996 Oct; 26(10):1197-201. PubMed ID: 8911707 [TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial. Bernstein IL; Bernstein DI; Dubb JW; Faiferman I; Wallin B J Allergy Clin Immunol; 1996 Aug; 98(2):317-24. PubMed ID: 8757209 [TBL] [Abstract][Full Text] [Related]
17. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Harrison TW; Oborne J; Newton S; Tattersfield AE Lancet; 2004 Jan; 363(9405):271-5. PubMed ID: 14751699 [TBL] [Abstract][Full Text] [Related]
18. Increased serum VDBP as a risk predictor for steroid resistance in asthma patients. Jiang H; Chi X; Zhang X; Wang J Respir Med; 2016 May; 114():111-6. PubMed ID: 27109820 [TBL] [Abstract][Full Text] [Related]
19. Does nedocromil sodium have a steroid sparing effect in adult asthmatic patients requiring maintenance oral corticosteroids? Goldin JG; Bateman ED Thorax; 1988 Dec; 43(12):982-6. PubMed ID: 2853457 [TBL] [Abstract][Full Text] [Related]
20. Effects of short-term oral corticosteroid intake on dietary intake, body weight and body composition in adults with asthma - a randomized controlled trial. Berthon BS; Gibson PG; McElduff P; MacDonald-Wicks LK; Wood LG Clin Exp Allergy; 2015 May; 45(5):908-919. PubMed ID: 25640664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]